Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Moss

Showing results (71-80 of 171) with videos related to

Pageof 18
Sort By:
Advances in Cancer Research|January 1, 1996
Strategies involved in developing an effective vaccine for EBV-associated diseasesD J Moss, C Schmidt, S Elliott, et al.
The Journal of General Virology|January 1, 1994
Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virusC Aitken, S K Sengupta, C Aedes, et al.
Journal of Virology|August 1, 1990
An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.
Pathology|April 1, 1979
Human malignant melanoma cell linesJ H Pope, L Morrison, D J Moss, et al.
International Journal of Cancer|June 15, 1985
Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell linesP G Parsons, D J Moss, C Morris, et al.
European Journal of Immunology|January 1, 1992
The specificity of recognition of a cytotoxic T lymphocyte epitopeS R Burrows, S J Rodda, A Suhrbier, et al.
Seminars in Immunology|April 1, 1992
Immune surveillance against Epstein-Barr virusD J Moss, S R Burrows, R Khanna, et al.
The Journal of Experimental Medicine|January 1, 1990
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)S R Burrows, T B Sculley, I S Misko, et al.
The Journal of General Virology|February 1, 1991
Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3I S Misko, C Schmidt, D J Moss, et al.
Scandinavian Journal of Immunology|April 1, 1991
Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitroC Schmidt, S R Burrows, D J Moss, et al.
Pageof 18

Showing results (71-80 of 171) with videos related to

Sort By:
Pageof 18
Advances in Cancer Research|January 1, 1996
Strategies involved in developing an effective vaccine for EBV-associated diseasesD J Moss, C Schmidt, S Elliott, et al.
The Journal of General Virology|January 1, 1994
Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virusC Aitken, S K Sengupta, C Aedes, et al.
Journal of Virology|August 1, 1990
An Epstein-Barr virus-specific cytotoxic T-cell epitope present on A- and B-type transformantsS R Burrows, I S Misko, T B Sculley, et al.
Pathology|April 1, 1979
Human malignant melanoma cell linesJ H Pope, L Morrison, D J Moss, et al.
International Journal of Cancer|June 15, 1985
Decreased calcium dependence of lymphoblastoid cell lines compared with Burkitt lymphoma cell linesP G Parsons, D J Moss, C Morris, et al.
European Journal of Immunology|January 1, 1992
The specificity of recognition of a cytotoxic T lymphocyte epitopeS R Burrows, S J Rodda, A Suhrbier, et al.
Seminars in Immunology|April 1, 1992
Immune surveillance against Epstein-Barr virusD J Moss, S R Burrows, R Khanna, et al.
The Journal of Experimental Medicine|January 1, 1990
An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3)S R Burrows, T B Sculley, I S Misko, et al.
The Journal of General Virology|February 1, 1991
Cytotoxic T lymphocyte discrimination between type A Epstein-Barr virus transformants is mapped to an immunodominant epitope in EBNA 3I S Misko, C Schmidt, D J Moss, et al.
Scandinavian Journal of Immunology|April 1, 1991
Oligopeptide induction of a secondary cytotoxic T-cell response to Epstein-Barr virus in vitroC Schmidt, S R Burrows, D J Moss, et al.
Pageof 18